IL-15, produced by monocytes, synergistically promotes CpG-mediated CLL proliferation independent of CLL mutation status, thus reversing the difference as usually seen between um-CLL and m-CLL (8, 107). The gene discussed is IL15; the disease is B-cell chronic lymphocytic leukemia.